Latest News in the pharma Industry

Policy & Regulation

Preliminar?y NICE Guidance Recommends Inlyta for the Treatment of Advanced Kidney Cancer

Preliminar?y NICE Guidance Recommends Inlyta for the Treatment of Advanced Kidney Cancer

4 Mar 2014

Read more 
CHMP Issues Positive Opinion for Tablet Formulatio?n of Merck's NOXAFIL (Posaconaz?ole)

CHMP Issues Positive Opinion for Tablet Formulatio?n of Merck's NOXAFIL (Posaconaz?ole)

3 Mar 2014

Read more 
Rx-360 Summary of the First Annual Report on Drug Shortages

Rx-360 Summary of the First Annual Report on Drug Shortages

28 Feb 2014

Read more 
NICE Recommendation Set to Leave Patients with Newly Diagnosed Advanced Melanoma Without Access to Yervoy (Ipilimumab)

NICE Recommendation Set to Leave Patients with Newly Diagnosed Advanced Melanoma Without Access to Yervoy (Ipilimumab)

26 Feb 2014

Read more 
FDA Approves KALYDECO (Ivacaftor) for Use in Eight Additional Mutations that Cause Cystic Fibrosis

FDA Approves KALYDECO (Ivacaftor) for Use in Eight Additional Mutations that Cause Cystic Fibrosis

25 Feb 2014

Read more 
A&C American Chemicals Received EXCiPACT Certification as Pharmaceutical Excipient Supplier

A&C American Chemicals Received EXCiPACT Certification as Pharmaceutical Excipient Supplier

21 Feb 2014

Read more 
FDA Initiates the Secure Supply Chain Pilot Programme to Enhance Security of Imported Drugs

FDA Initiates the Secure Supply Chain Pilot Programme to Enhance Security of Imported Drugs

20 Feb 2014

Read more 
FDA and European Medicines Agency Strengthen Collaboration in Pharmacovigilance Area

FDA and European Medicines Agency Strengthen Collaboration in Pharmacovigilance Area

20 Feb 2014

Read more 
Selvita Group Receives GMP Certificate

Selvita Group Receives GMP Certificate

19 Feb 2014

Read more 
Transport Validation: New Considerations by Annex 15

Transport Validation: New Considerations by Annex 15

19 Feb 2014

Read more 
FDA Grants Accelerated Approval to ibrutinib for the Treatment of Patients with CLL

FDA Grants Accelerated Approval to ibrutinib for the Treatment of Patients with CLL

14 Feb 2014

Read more 
EU Q&A on Importation of APIs

EU Q&A on Importation of APIs

6 Feb 2014

Read more